Dominick DiPaolo

Overview

Dominick DiPaolo received $1M in total compensation, including $188K in salary, at Matinas BioPharma Holdings in 2017.

Source: SEC filing on September 24, 2018.

Related executives

We found nine more executives who work or worked at Matinas BioPharma Holdings.

Jerome Jabbour

Matinas BioPharma Holdings

Chief Executive Officer

James Ferguson

Matinas BioPharma Holdings

Chief Medical Officer

Theresa Matkovits

Matinas BioPharma Holdings

Chief Development Officer

Keith Kucinski

Matinas BioPharma Holdings

Chief Financial Officer

Roelof Rongen

Matinas BioPharma Holdings

Chief Executive Officer

Raphael Mannino

Matinas BioPharma Holdings

Chief Scientific Officer

Gary Gaglione

Matinas BioPharma Holdings

Chief Financial Officer

Douglas Kling

Matinas BioPharma Holdings

Senior Vice President, Clinical Development & Project Management

You may also like